We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Easy-To-Use Point-Of-Care Testing Device Accurately Measures Cortisol Levels in Blood

By LabMedica International staff writers
Posted on 04 Sep 2024

Stress manifests in various forms, and the inability to manage high stress levels can lead to severe health problems like depression and Alzheimer's disease. More...

The development of a cost-effective, reproducible, and easy-to-use point-of-care testing device that accurately measures cortisol—a key stress biomarker in the blood—has been a significant goal of researchers. Such a device could greatly facilitate the quick diagnosis of elevated cortisol levels, thereby significantly enhancing quality of life. However, the electrodes used in currently available devices are not stable under varying conditions such as changes in pH and temperature, resulting in a limited shelf life and difficulties in commercial production.

Now, researchers at Xi'an Jiaotong-Liverpool University (XJTLU, Suzhou, China) have developed an innovative cortisol detector that addresses these challenges. Traditional cortisol sensors use reference electrodes with a silver layer that tends to oxidize and destabilize during electrochemical measurements. In the new study published in the journal Talanta, the researchers introduced iridium oxide nanoparticles to coat the silver layer, significantly enhancing the stability, sensitivity, and reproducibility of cortisol measurements in point-of-care settings. This is the first application of iridium oxide in this manner. The resulting device is simple and affordable, capable of detecting cortisol levels at concentrations 3,000 times lower than the typical cortisol range found in blood, making it highly suitable for commercial use. Additionally, the iridium oxide-modified electrodes have increased the selectivity of the tests, improving the device’s overall efficacy.

"One problem with the current solutions is that there is much similarity between cortisol and other hormones such as progesterone, testosterone, and corticosterone. This means it is difficult for the detectors to tell them apart,” said Dr. Graham Dawson, XJTLU Associate Professor and co-author. “Our iridium oxide-modified electrode is selective enough to distinguish the different hormones and helps to solve this issue."

Related Links:
XJTLU


New
Gold Member
Genetic Type 1 Diabetes Risk Test
T1D GRS Array
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Gold Member
Hybrid Pipette
SWITCH
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Industry

view channel
Image: The LIAISON NES molecular point-of-care platform (Photo courtesy of Diasorin)

Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform

Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.